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AbstrACt
Objective This project aimed to develop and propose 
a standardised reporting guideline for kidney disease 
research and clinical data reporting, in order to improve 
kidney disease data quality and integrity, and combat 
challenges associated with the management and 
challenges of ‘Big Data’.
Methods A list of recommendations was proposed for 
the reporting guideline based on the systematic review 
and consolidation of previously published data collection 
and reporting standards, including PhenX measures and 
Minimal Information about a Proteomics Experiment (MIAPE). 
Thereafter, these recommendations were reviewed by domain- 
specialists using an online survey, developed in Research 
Electronic Data Capture (REDCap). Following interpretation 
and consolidation of the survey results, the recommendations 
were mapped to existing ontologies using Zooma, Ontology 
Lookup Service and the Bioportal search engine. Additionally, 
an associated eXtensible Markup Language schema was 
created for the REDCap implementation to increase user 
friendliness and adoption.
results The online survey was completed by 53 
respondents; the majority of respondents were dual clinician- 
researchers (57%), based in Australia (35%), Africa (33%) 
and North America (22%). Data elements within the reporting 
standard were identified as participant- level, study- level and 
experiment- level information, further subdivided into essential 
or optional information.
Conclusion The reporting guideline is readily employable 
for kidney disease research projects, and also adaptable for 
clinical utility. The adoption of the reporting guideline in kidney 
disease research can increase data quality and the value 
for long- term preservation, ensuring researchers gain the 
maximum benefit from their collected and generated data.
IntrOduCtIOn
‘Big Data’ and bioinformatics have become 
crucial components of modern biomedical 
research and healthcare.1 In biomedical 
research, ‘Big Data’, commonly character-
ised by volume and variety, refers to data sets 
which are too large or complex to be analysed 
using traditional methods, often requiring 
the use of computational analyses to derive 
biological meaning.2 Biomedical ‘Big Data’ has 
many potential fields of application, including 
personalised medicine, predictive modelling 
and clinical decision support, and disease and 
safety surveillance.3 In the field of nephrology, 
the use of ‘Big Data’ has led to the improved 
understanding of the pathological processes 
and the underlying aetiologies associated with 
kidney disease,4 as well as the increased identi-
fication of genetic kidney diseases5 6 and novel 
diagnostic methods for these diseases.7
Challenges associated with the data lifecycle, 
including the collection, management, storage 
and analysis of data, hamper the use and poten-
tial benefit of ‘Big Data’. These factors are 
compounded by additional biomedical research 
challenges, such as the inability to recruit suffi-
cient sample sizes, as well as the lack of research 
capacity, funding and infrastructure, especially 
in low- income regions.8 9 Additionally, the use 
strengths and limitations of this study
 ► The reporting guideline references and is mapped 
to standardised collection measures and biomedical 
ontologies found in the Phenotypes and eXposures 
Toolkit, the Ontology Lookup Service and Bioportal, 
respectively.
 ► The reporting guideline was reviewed by global 
domain- specialists.
 ► Limited survey feedback was received from Asian 
and South American countries.
 ► An eXtensible Markup Language (XML) schema was 
developed to promote user- friendliness and main-
tain the relationship between the reporting guide-
line’s sub- sections.
 ► The XML schema does not inherently incorporate 
mapped ontologies; therefore, strategies are being 
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of ill- defined ontologies, data dictionaries and data manage-
ment plans, contribute to data incompatibility and prevents 
researchers from reaping the maximum benefit from their 
collected and generated data.10
Standardising clinical and research data collection, 
reporting, management or storage can combat these chal-
lenges, supporting the effective integration of ‘Big Data’ and 
bioinformatics in biomedical research,11 12 enhancing data 
compatibility, interoperability, reproducibility and reuse,12 
and facilitating data sharing and collaboration.11 The use of 
biomedical reporting standards and ontologies facilitate data 
standardisation by promoting the use of or adherence to 
common terminology and(or) reporting criteria.10 13 To this 
end, several initiatives have been driving data standardisation 
efforts in biomedical research. The consensus measures for 
Phenotypes and eXposures (PhenX) Toolkit ( www. phenx-
toolkit. org), has proposed phenotype collection tools for 
harmonised data collection, although some tools are limited 
in terms of applicability to low- resource settings.14 Similar 
aims are being driven by FAIRsharing ( www. fairsharing. 
org),15 a dynamic standards database which aims to promote 
FAIR (findable, accessible, interoperable and reusable) prin-
ciples,16 and the Global Alliance for Genomics and Health 
( www. ga4gh. org), a policy- framing and technical standards- 
setting organisation. Multiple kidney- associated ontologies 
which define known kidney diseases and assist routine data 
studies and case identification have previously been devel-
oped, including the chronic kidney disease ontology,17 
as well as the renal subsections in the gene ontology, the 
human phenotype ontology18 and the Systematized Nomen-
clature of Medicine- Clinical Terms.19 However, no reporting 
guideline has previously been constructed for kidney disease 
clinical and research data reporting.
The Human Heredity and Health in Africa’s (H3Africa) 
Bioinformatics Network’s (H3ABioNet, www. h3abionet. 
org)20 21 Data & Standards work package aims to develop 
domain- specific data reporting standards and data dictio-
naries, applicable to the H3Africa consortium, in order to 
specifically address the data management concerns in low- 
resource and low- income regions, affected by global health 
concerns, but lacking capacity to address these concerns. 
By consolidating and harmonising several published ontol-
ogies, collection standards and reporting standards, and 
consulting domain- specialists through an open online 
survey, the project drew from the experience of previous stan-
dardisation initiatives and aimed to develop a multipurpose 
reporting guideline which focused on the reporting of both 
clinical and research data within the kidney disease field, 
entitled, ‘The Minimum Information Required Guideline 




No patients or public were included in the methodology 
of the study. The survey employed in the study was strictly 
distributed to domain- specialists, hereafter defined.
development of draft
Following the review of previously published litera-
ture and standards, several recommendations for the 
‘Minimum Information Required Guideline: Kidney 
Disease Research and Clinical Data Reporting’ standards 
were proposed. The standards included were separated 
into two streams, the standards relevant to the collec-
tion of clinical data and those relevant to the reporting 
of research data. The standards relevant to clinical data 
collection included the H3Africa Standard Case Report 
Form ( www. h3abionet. org/ data- standards/ datastds), 
the CKDO and various collection measures hosted on 
PhenX. The standards relevant to research data reporting 
included various experimental reporting guidelines 
hosted on FAIRsharing, such as MIAPE, MIDE, MIRAGE, 
MINSEQE, MIAME and more, from which common 
study- specific and experiment- specific elements were 
derived. Based on these recommendations, a reporting 
standard was drafted, which divided the proposed recom-
mendations into three subsections; participant (patient), 
study- level and experiment- level information. The devel-
oped draft aimed to be both comprehensive and adapt-
able for both acquired and inherited kidney diseases, 
containing and querying elements specific to one or 
both types. Thereafter, recommendations (henceforth 
referred to as elements) were manually defined using 
ontologies found through the BioPortal search engine,22 
the Ontology Lookup Service at the European Bioinfor-
matics Institute23 and the Zooma annotation tool.
Online survey
To remove any existing reporting inconsistencies, domain- 
specialists, consisting of kidney disease researchers and 
clinicians, were consulted to review the proposed elements 
using an online survey. Domain- specialists were defined as 
both clinicians and researchers that have been involved 
in kidney disease research for at least a year, as part of an 
existing collaborative kidney disease research group or 
network (including the H3Africa Kidney Disease Research 
Network, the Australian KidGen Collaborative and Renal 
Genetics Flagships, Kidney Research UK and The Renal 
Network) and contacted via email. Domain- specialists were 
asked to evaluate, harmonise and consolidate the proposed 
elements, as well as identify which elements represented 
essential (E) or optional (O) information, and propose 
additional elements. Elements were classified as either E or 
O based on the E% percentage of E votes received. This 
percentage was calculated by dividing the total number of 
E votes by the number of votes made for a given element. 
Elements with lower than 50% were classified as O, while 
elements higher than 70% were classified as E, and 
elements within the 50–70 E% were classified with discre-
tion based on correlations with the previously developed 
reporting guidelines and standard collection measures. 
Additional suggestions, not included in the draft, made by 
respondents were similarly classified.
Because the survey was constructed to be open, no limita-
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Figure 1 Survey response to proposed participant- level 
information.
Figure 2 Survey response to proposed study- and 
experiment- level information.
and respondents were encouraged to distribute the survey 
within their own networks. The online survey was devel-
oped, and study data were collected and managed using 
Research Electronic Data Capture (REDCap),24 hosted at 
The Centre for Proteomic and Genomic Research. The 
online survey consisted of 4 sections and 77 fields (online 
supplementary file 1). REDCap was employed for security 
and maintenance purposes.
development of eXtensible Markup Language
To supplement usability and user- friendliness, an associated 
eXtensible Markup Language (XML) schema was designed 
to carry all the data and metadata within the reporting 
guideline and allow data exchange between dissimilar 
systems. The XML schema defines the rules of validation 
for each element, as well as the datatype, atomic units and 
validation rules for each element, to ensure reporting 
correctness. Additionally, due to its user- friendliness and 
availability to research institutions worldwide, the XML 
schema was designed for implementation in REDCap.
resuLts
The online survey was completed by 53 international 
domain specialists. Of these respondents, 29% were 
working as clinicians, 14% were working as researchers 
and 57% were working as dual clinician- researchers. The 
majority of respondents had between 10 and 20 years’ 
experience in the field (41%), while 37% of respondents 
had more than 20 years’ experience in the field, 13% had 
more than 5 years’ experience’ in the field and 9% had 
less than 5 years’ experience in the field. The majority of 
respondents were based in Australia (35%), followed by 
Africa (33%), North America (22%), Europe (9%) and 
Asia (2%). The raw survey results can be found in online 
supplementary file 2. Figures 1 and 2 illustrate the survey 
response to the proposed elements. Furthermore, respon-
dents also proposed additional elements which shaped 
the final structure of the reporting guideline, including, 
but not limited to, congenital conditions, histopathology, 
language, physical activity and more.
The Minimum Information Required Guideline: 
Kidney Disease Research and Clinical Data Reporting is 
summarised in table 1.
The quintessential information reported using the stan-
dard can be separated into three fields; participant- level, 
study- level and experiment- level information. The stan-
dard further divides elements into essential and optional 
information. Optional elements refer to information 
which is not necessary for the interoperation of studies 
within the same field but useful for integrating studies 
from varying disease fields. Participant- level information 
contains 13 subsections of varying essential and optional 
elements, including demographics, lifestyle factors, 
anthropometrics, blood pressure, adverse drug reactions, 
Urine- Related Test Index, kidney disease history, sample- 
specific information, kidney disease- related informa-
tion, prescribed medication, non- prescribed medication 
and therapy. Study- level information includes various 
elements which describe the details of a given study, 
including essential elements such as study ID, research 
institute and study design, and optional elements such 
as study duration, study start date and Pubmed unique 
identifier. Finally, experiment- level information includes 
various elements which describe the various experiments 
within a given study, including essential elements such 
as biospecimen type, instrumentation employed, sample 
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experimental aim, and optional elements such as output 
location which describes where the data will be saved.
The complete reporting guideline can be obtained 
from both the H3ABioNet website ( www. h3abionet. org/ 
data- standards/ datastds) as well as FAIRsharing (https:// 
fairsharing. org/ bsg- s001385/), specifying each element’s 
data type, collection format and (or) accepted values, and 
related ontologies and standards. Herein, the Ontology 
ID column contains the most appropriate ontology which 
the element is mapped to while the Concordant Ontolo-
gies and Concordant Standards columns describe ontol-
ogies and standards which include similar data elements. 
These lists are not meant to be comprehensive or exhaus-
tive, but to illustrate the utilisation and overlap with 
existing resources. A comprehensive guideline explaining 
how to employ the reporting guideline, along with the 
associated REDCap XML schema, locally can be found in 
online supplementary file 3. In addition, online supple-
mentary file 4 contains an example entry of the reporting 
guideline, and online supplementary file 5 contains an 
illustration of the REDCap XML schema.
dIsCussIOn
The Minimum Information Required Guideline: Kidney 
Disease Research and Clinical Data Reporting is a freely 
accessible, harmonised reporting guideline which can 
be employed or adapted for kidney disease research 
and healthcare and categorises information as essential 
or optional, as well as participant, study and experiment 
specific. Standardising how this information is captured, 
deposited, shared and published in a comparable and 
consistent manner is crucial for researchers to better 
understand a given study and subsequently interpret the 
data generated and conclusions made. The primary intent 
of the reporting guideline is to encourage harmonised 
data collection when launching new projects within the 
kidney disease research field. Ultimately, this will enhance 
the overall research community’s capacity for conducting 
high- quality, interoperable and reusable research, adding 
long- term value to the collected clinical data and gener-
ated research data and encouraging more collaborative 
efforts worldwide. Similarly, the reporting guideline can 
also be employed retrospectively for data abstraction from 
existing or ongoing studies when reporting to a larger 
database, enabling the previously mentioned efforts.
Although certain elements within the standard can be 
incorporated into a case report form, the reporting guide-
line contains elements that need to be completed specifi-
cally by healthcare or research professionals, therefore the 
reporting standard is designed for use by research clinicians 
and healthcare workers, researchers, data managers and 
bioinformaticians involved in kidney disease research. The 
reporting guideline was not developed to replace the case 
report form but rather to provide a set of data reporting 
rules for researchers to adhere too. Defining the informa-
tion as essential or optional permits the reporting guide-
line to be adaptable for both acquired and inherited kidney 
disease research, therefore elements such as congenital 
conditions and histopathology are defined as optional. 
The reporting standard goes beyond listing ‘minimum 
required’ data elements and aims to provide a comprehen-
sive data dictionary, with standardised response options, 
which can be adapted for broad use. Therefore, employing 
the reporting standard allows comprehensive characteri-
sation of research studies being conducted in the kidney 
disease research field, as well as the experiments and partic-
ipants within these studies, supporting integrative analysis 
and improved biological interpretation.
The reporting standard is also accompanied by an asso-
ciated REDCap XML schema. This was done to enable 
user friendliness and broad adoption of the standard as 
a data capturing and governance tool, allowing accurate 
and seamless duplication and reuse.25 XML has been used 
extensively for describing data in many applications for 
storage or transport.25 The language, by its design, allows 
for extensibility and self- description. Its openly docu-
mented standards, wide adoption and support in many 
applications and existing tools make it a good first choice 
for describing scientific data that is exchanged between 
healthcare systems.25 It has previously been used in health 
reporting for such purposes.26 27 Currently, ontologies 
cannot be intrinsically linked to the guideline elements 
within the REDCap XML. In the future, we aim to provide 
base XML schemas which are adaptable for broad imple-
mentation on various data capturing platforms. This will 
allow us to link the guideline elements to the mapped 
ontologies. Ultimately, the ontologies serve to promote 
FAIR reporting by adding an underlying layer of meta-
data and understanding to the overall dataset.
Broad adoption of the developed reporting stan-
dard has the potential to significantly reduce data and 
reporting inconsistency and redundancy across systems, 
promoting collaboration and(or) interoperability 
between projects.28 29 Promoting such large- scale use 
could allow for improved data mapping in clinical regis-
tries, improving data quality and interoperability.30 As 
previously exhibited in oncology research, broad adop-
tion of a reporting standard can maximise the value 
and impact of research studies as well as the associated 
research data.31 This is because research redundancy is 
reduced, and interpretable research outputs and compre-
hensive datasets are produced.31 A given standard may be 
more widely adopted if advocated by databases, funding 
bodies and scientific journals, geared towards kidney 
disease research, specifically.
The Minimum Information Required Guideline: Kidney 
Disease Research and Clinical Data Reporting aims to 
promote FAIR reporting and will therefore be added to 
the FAIRsharing database, as this allows for continuous 
record maintenance and improvement, providing a point 
of contact for the standard, as well as related support mate-
rial (https:// doi. org/ 10. 25504/ FAIRsharing. fCAD2Z).15 
Bearing in mind the diverse target group the reporting 
standard aims to accommodate, various methods of imple-
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solutions for collaborative efforts. Additional elements 
will be investigated for incorporation into the standard, 
including environmental factors, dyslipidaemia and diet.
To promote the adoption of the reporting guideline, 
we hope to employ the reporting guideline within our 
own consortia studies, and advocate use on an interna-
tional platform. Ultimately, the reporting guideline has 
the potential to support both the H3Africa community 
as well as the kidney disease research community at large 
with current and future research.
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